Conference Coverage

VIDEO: Unraveling Alzheimer’s pathogenesis while testing lifestyle interventions


 

EXPERT ANALYSIS FROM THE ADRD SUMMIT 2016

References

BETHESDA, MD. – Alzheimer’s disease is not the failure of a single type of cell – or even a single physiologic system, so while the search for effective treatments goes on, basic research must continue to unravel many of its fundamental mechanisms, according to Dr. Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center in Rochester, Minn.

But in lieu of available treatments that target the underlying pathology of Alzheimer’s, trials must continue to test lifestyle interventions with diet and exercise that in preliminary studies have started proving their worth in decreasing the risk of cognitive decline or delaying its onset.

Dr. Petersen discussed these issues in an interview at the Alzheimer’s Disease–Related Dementias 2016 Summit, sponsored by the National Institutes of Health.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

Drug interaction myths
MDedge Internal Medicine
Health linked closely to ‘American Dream,’ surgeon general says
MDedge Internal Medicine
Expert shares recipe for being a great ward attending
MDedge Internal Medicine
Higher levels of function before hip fracture tied to greater fears of falling at 1 year
MDedge Internal Medicine
Heart attack patients getting younger, fatter, and less healthy
MDedge Internal Medicine
Prepsychosis links with elevated metabolic syndrome
MDedge Internal Medicine
Losmapimod failed to beat placebo in acute MI trial
MDedge Internal Medicine
VIDEO: New ACC consensus guidance addresses nonstatin therapies
MDedge Internal Medicine
Hospitalists pitch value ideas in Shark Tank
MDedge Internal Medicine
VIDEO: Fire and Ice - Which catheter ablation approach is best in AF?
MDedge Internal Medicine